The results showed that at 48 hours after PPP2R3A knockdown, the proliferation of liver cancer cells was inhibited (P < .05) compared with that of control cells, and this difference in the proliferation rate continued to increase with more time in culture (P < .01; Figure 3A). The gene discussed is PPP2R3A; the disease is liver cancer.